DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,000 | +24.6% | 8,010 | +57.7% | 0.00% | – |
| Q2 2023 | $57,000 | +72.7% | 5,078 | +72.8% | 0.00% | – |
| Q1 2023 | $33,000 | -40.0% | 2,938 | -37.9% | 0.00% | – |
| Q4 2022 | $55,000 | +175.0% | 4,734 | +205.6% | 0.00% | – |
| Q3 2022 | $20,000 | +122.2% | 1,549 | +15.5% | 0.00% | – |
| Q2 2022 | $9,000 | -69.0% | 1,341 | -55.4% | 0.00% | – |
| Q1 2022 | $29,000 | -67.0% | 3,009 | -59.5% | 0.00% | – |
| Q4 2021 | $88,000 | +8.6% | 7,438 | +50.4% | 0.00% | – |
| Q3 2021 | $81,000 | +88.4% | 4,946 | +140.1% | 0.00% | – |
| Q2 2021 | $43,000 | +79.2% | 2,060 | +33.6% | 0.00% | – |
| Q1 2021 | $24,000 | +71.4% | 1,542 | +135.1% | 0.00% | – |
| Q4 2020 | $14,000 | – | 656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |